NSE BSE
eris lifesciences limited stock

ERIS LIFESCIENCES LIMITED Share Price

- - (%)
Sector: -

21154

540596

ERIS

img img img img
No Data Available

ERIS LIFESCIENCES LIMITED Share Price Update


As of the latest trading session, ERIS LIFESCIENCES LIMITED share price is currently at 897.25, which is up by 10.75 from its previous closing. Today, the stock has fluctuated between 866.10 and 900.15. Over the past year, ERIS LIFESCIENCES LIMITED has achieved a return of 39.24 %. In the last month alone, the return has been 1.86 %.

ERIS LIFESCIENCES LIMITED Performance

Day Range

Low866.10 High900.15
897.25

52 Week Range

Low 605.00 High 971.90
897.25

Open Price

886.50

Prev. Close

886.50

Volume (Shares)

11175.00

Total traded value

100.26

Upper Circuit

930.80

Lower Circuit

842.20

Note: The current prices & values are delayed, Login to your account for live updates.

ERIS LIFESCIENCES LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 12201.90
PE Ratio (TTM) 35.07
Book Value / Share 180.23
Beta 0.52
ROE 19.23%
EPS (TTM) 25.58
Dividend Yield 0.82%
Net Profit Qtr (Cr) 31.66

ERIS LIFESCIENCES LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2023 (Values in Cr)
Revenue 315.96
Operating Expense 293.20
Net Profit 31.66
Net Profit Margin (%) 10.02
Earnings Per Share (EPS) 2.33
EBITDA 77.86
Effective Tax Rate (%) 8.63
Particulars SEP 2023 (Values in Cr)
Revenue 402.26
Operating Expense 296.77
Net Profit 117.81
Net Profit Margin (%) 29.28
Earnings Per Share (EPS) 8.66
EBITDA 151.47
Effective Tax Rate (%) 1.75
Particulars JUN 2023 (Values in Cr)
Revenue 404.29
Operating Expense 282.78
Net Profit 110.74
Net Profit Margin (%) 27.39
Earnings Per Share (EPS) 8.14
EBITDA 159.52
Effective Tax Rate (%) 16.43
Particulars MAR 2023 (Values in Cr)
Revenue 308.36
Operating Expense 223.34
Net Profit 87.84
Net Profit Margin (%) 28.48
Earnings Per Share (EPS) 6.46
EBITDA 115.75
Effective Tax Rate (%) 8.03
Particulars DEC 2022 (Values in Cr)
Revenue 326.76
Operating Expense 225.26
Net Profit 99.38
Net Profit Margin (%) 30.41
Earnings Per Share (EPS) 7.31
EBITDA 129.87
Effective Tax Rate (%) 9.84
Particulars MAR 2023 (Values in Cr)
Revenue 1307.12
Operating Expense 911.07
Net Profit 398.01
Net Profit Margin (%) 30.44
Earnings Per Share (EPS) 29.27
EBITDA 522.38
Effective Tax Rate (%) 8.90
Particulars MAR 2022 (Values in Cr)
Revenue 1193.77
Operating Expense 786.18
Net Profit 417.19
Net Profit Margin (%) 34.94
Earnings Per Share (EPS) 30.70
EBITDA 512.99
Effective Tax Rate (%) 9.01
Particulars MAR 2021 (Values in Cr)
Revenue 1088.65
Operating Expense 729.93
Net Profit 350.61
Net Profit Margin (%) 32.20
Earnings Per Share (EPS) 25.82
EBITDA 427.30
Effective Tax Rate (%) 9.84
Particulars MAR 2020 (Values in Cr)
Revenue 1003.76
Operating Expense 711.36
Net Profit 291.27
Net Profit Margin (%) 29.01
Earnings Per Share (EPS) 21.23
EBITDA 370.32
Effective Tax Rate (%) 9.98
Particulars MAR 2019 (Values in Cr)
Revenue 881.13
Operating Expense 617.26
Net Profit 285.38
Net Profit Margin (%) 32.38
Earnings Per Share (EPS) 20.75
EBITDA 366.15
Effective Tax Rate (%) 8.46
Particulars MAR 2023 (Values in Cr)
Book Value / Share 161.48
ROE % 18.23
ROCE % 16.69
Total Debt to Total Equity 0.23
EBITDA Margin 32.52
Particulars MAR 2022 (Values in Cr)
Book Value / Share 140.36
ROE % 23.29
ROCE % 24.45
Total Debt to Total Equity 0.03
EBITDA Margin 37.94
Particulars MAR 2021 (Values in Cr)
Book Value / Share 116.10
ROE % 24.72
ROCE % 26.81
Total Debt to Total Equity 0.00
EBITDA Margin 36.26
Particulars MAR 2020 (Values in Cr)
Book Value / Share 95.47
ROE % 24.24
ROCE % 24.80
Total Debt to Total Equity 0.07
EBITDA Margin 35.74
Particulars MAR 2019 (Values in Cr)
Book Value / Share 83.66
ROE % 28.94
ROCE % 26.04
Total Debt to Total Equity 0.27
EBITDA Margin 38.36
Particulars MAR 2023 (Values in Cr)
Book Value / Share 163.39
ROE % 19.23
ROCE % 19.94
Total Debt to Total Equity 0.08
EBITDA Margin 39.27
Particulars MAR 2022 (Values in Cr)
Book Value / Share 141.11
ROE % 23.88
ROCE % 25.68
Total Debt to Total Equity 0.00
EBITDA Margin 42.20
Particulars MAR 2021 (Values in Cr)
Book Value / Share 116.03
ROE % 24.39
ROCE % 26.48
Total Debt to Total Equity 0.00
EBITDA Margin 38.55
Particulars MAR 2020 (Values in Cr)
Book Value / Share 95.72
ROE % 23.72
ROCE % 24.21
Total Debt to Total Equity 0.07
EBITDA Margin 36.31
Particulars MAR 2019 (Values in Cr)
Book Value / Share 84.06
ROE % 28.20
ROCE % 25.57
Total Debt to Total Equity 0.27
EBITDA Margin 40.85
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 58.45
Total Assets 3667.32
Total Liabilities 3667.32
Total Equity 2220.67
Share Outstanding 135992238
Price to Book Ratio 3.50
Return on Assets (%) 10.42
Return on Capital (%) 12.53
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 52.32
Total Assets 2272.13
Total Liabilities 2272.13
Total Equity 1908.20
Share Outstanding 135930197
Price to Book Ratio 4.88
Return on Assets (%) 17.87
Return on Capital (%) 20.79
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 38.27
Total Assets 1834.78
Total Liabilities 1834.78
Total Equity 1576.42
Share Outstanding 135780653
Price to Book Ratio 5.21
Return on Assets (%) 19.35
Return on Capital (%) 22.53
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 67.32
Total Assets 1552.30
Total Liabilities 1552.30
Total Equity 1296.33
Share Outstanding 135780653
Price to Book Ratio 3.85
Return on Assets (%) 19.10
Return on Capital (%) 22.87
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 7.50
Total Assets 1553.66
Total Liabilities 1553.66
Total Equity 1168.82
Share Outstanding 137519783
Price to Book Ratio 7.66
Return on Assets (%) 18.71
Return on Capital (%) 24.87
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 47.64
Total Assets 2783.65
Total Liabilities 2783.65
Total Equity 2221.88
Share Outstanding 135992238
Price to Book Ratio 3.50
Return on Assets (%) 14.29
Return on Capital (%) 15.68
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 46.10
Total Assets 2150.41
Total Liabilities 2150.41
Total Equity 1918.55
Share Outstanding 135930197
Price to Book Ratio 4.88
Return on Assets (%) 19.40
Return on Capital (%) 21.75
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 32.65
Total Assets 1754.80
Total Liabilities 1754.80
Total Equity 1575.46
Share Outstanding 135780653
Price to Book Ratio 5.21
Return on Assets (%) 19.97
Return on Capital (%) 22.25
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 64.95
Total Assets 1483.12
Total Liabilities 1483.12
Total Equity 1299.70
Share Outstanding 135780653
Price to Book Ratio 3.85
Return on Assets (%) 19.63
Return on Capital (%) 22.41
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 6.47
Total Assets 1470.37
Total Liabilities 1470.37
Total Equity 1156.00
Share Outstanding 137519783
Price to Book Ratio 7.66
Return on Assets (%) 19.40
Return on Capital (%) 24.69
Particulars MAR 2023 (Values in Cr)
Net Income 404.64
Cash from Operations 368.94
Cash from Investing -982.10
Cash from Financing 688.02
Net change in Cash -2.33
Free Cash Flow 1210.36
Particulars MAR 2022 (Values in Cr)
Net Income 442.19
Cash from Operations 461.54
Cash from Investing -319.61
Cash from Financing -44.69
Net change in Cash 13.95
Free Cash Flow 582.58
Particulars MAR 2021 (Values in Cr)
Net Income 394.49
Cash from Operations 443.89
Cash from Investing -323.35
Cash from Financing -82.39
Net change in Cash -30.39
Free Cash Flow 469.65
Particulars MAR 2020 (Values in Cr)
Net Income 331.35
Cash from Operations 322.93
Cash from Investing 123.23
Cash from Financing -334.59
Net change in Cash 59.80
Free Cash Flow 474.21
Particulars MAR 2019 (Values in Cr)
Net Income 317.35
Cash from Operations 294.62
Cash from Investing -5.05
Cash from Financing -221.05
Net change in Cash -3.10
Free Cash Flow 332.62
Particulars MAR 2023 (Values in Cr)
Net Income 436.91
Cash from Operations 400.11
Cash from Investing -513.29
Cash from Financing 193.74
Net change in Cash 2.77
Free Cash Flow 711.37
Particulars MAR 2022 (Values in Cr)
Net Income 458.53
Cash from Operations 452.31
Cash from Investing -267.63
Cash from Financing -88.42
Net change in Cash 13.35
Free Cash Flow 505.59
Particulars MAR 2021 (Values in Cr)
Net Income 388.89
Cash from Operations 463.44
Cash from Investing -347.86
Cash from Financing -81.12
Net change in Cash -33.58
Free Cash Flow 489.06
Particulars MAR 2020 (Values in Cr)
Net Income 323.59
Cash from Operations 315.58
Cash from Investing 126.73
Cash from Financing -333.52
Net change in Cash 58.46
Free Cash Flow 464.30
Particulars MAR 2019 (Values in Cr)
Net Income 311.77
Cash from Operations 286.17
Cash from Investing 2.08
Cash from Financing -220.73
Net change in Cash -2.34
Free Cash Flow 323.58
Company Name Price P/E P/B Market Cap 52 Week Low/High
ERIS LIFESCIENCES LIMITED 897.15 31.59 5.06 12205.50 605.20 / 971.00
BLISS GVS PHARMA LTD 110.40 12.07 1.19 1155.79 71.00 / 148.95
CIPLA LTD 1403.90 26.62 4.24 113350.18 913.20 / 1519.00
FERMENTA BIOTECH LIMITED 162.85 0.00 1.67 479.28 132.30 / 214.00
GLAXOSMITHKLINE PHARMA LT 2355.75 57.70 22.44 39907.83 1275.05 / 2649.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
ERIS LIFESCIENCES LIMITED 897.15 35.07 4.97 12205.50 605.20 / 971.00
AMRUTAJAN HEALTH LTD 743.15 48.83 8.20 2148.49 556.05 / 802.60
ASTRAZENECA PHARMA IND LT 5757.35 90.24 21.97 14393.38 3131.10 / 7208.00
BLISS GVS PHARMA LTD 110.40 15.25 1.16 1155.79 71.00 / 148.95
ABBOTT INDIA LIMITED 26643.70 47.13 15.30 56617.86 20594.25 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 877.90
  • 26 Days 869.90
  • 10 Days 873.70
  • 50 Days 870.70
  • 12 Days 876.90
  • 100 Days 874.20
  • 20 Days 874.60
  • 200 Days 778.10
880.83
PIVOT
First Resistance 896.67
Second Resistance 906.83
Third Resistance 922.67
First Support 870.67
Second Support 854.83
Third Support 844.67
RSI 47.49
MACD 6.99
Commodity Channel Index (CCI) 30.14
ADX 17.18
Williams % R -30.47

Over 1 Month

down

1.86

Over 3 Months

down

2.75

Over 6 Months

down

-4.99

Over 1 Year

down

39.24

Over 3 Years

down

7.72

Over 5 Years

down

7.76

ERIS LIFESCIENCES LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

ERIS LIFESCIENCES LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
15.9
Promoter Holdings
54.9
FII
14.27
DII
14.91
Promoter Shares(Pledge Percentage)
18.51
Name Category Shares Shares%
Amit Indubhushan Bakshi Shareholding of Promoter and Promoter Group 5.8335144E7 42.88
Emerald Investments Limited Public Shareholding 9886882.0 7.27
Hdfc Small Cap Fund Public Shareholding 8973223.0 6.6
Rakesh Shah Public Shareholding 6640981.0 4.88
Inderjeet Singh Negi Shareholding of Promoter and Promoter Group 5939833.0 4.37
Rajendrakumar Rambhai Patel Shareholding of Promoter and Promoter Group 5939834.0 4.37
Uti Flexi Cap Fund Public Shareholding 5630875.0 4.14
Kaushal Kamleshkumar Shah Shareholding of Promoter and Promoter Group 4468833.0 3.29
Bhikhalal Chimanlal Shah Public Shareholding 3753566.0 2.76
Hetal Rasiklal Shah Public Shareholding 3503728.0 2.58
Franklin India Smaller Companies Fund Public Shareholding 1988900.0 1.46
Inreal Ventures Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Shah & Co. Shareholding of Promoter and Promoter Group 0.0 0.0
Mrudang Hiren Vakil (huf) Shareholding of Promoter and Promoter Group 0.0 0.0
Kaushal Kamlesh Shah (huf) Shareholding of Promoter and Promoter Group 0.0 0.0
Kamlesh Rasiklal Shah (huf) Shareholding of Promoter and Promoter Group 0.0 0.0
Pragnesh Bharatkumar Shah (huf) Shareholding of Promoter and Promoter Group 0.0 0.0
Pragnesh Bharatkumar Shareholding of Promoter and Promoter Group 0.0 0.0
Pinky Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Alpana Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Bakulaben Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Bharatbhai Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Saanvi Kaushal Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Karmm Kaushal Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Kajal Mrudang Vakil Shareholding of Promoter and Promoter Group 0.0 0.0
Shilpaben Kamleshkumar Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Kamleshkumar Rasiklal Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Sweta Kaushal Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Rajendrakumar Rambhai Patel Huf Shareholding of Promoter and Promoter Group 0.0 0.0
Hetal Bholabhai Patel Shareholding of Promoter and Promoter Group 0.0 0.0
Jagdish Bholabhai Patel Shareholding of Promoter and Promoter Group 0.0 0.0
Ambaben Patel Shareholding of Promoter and Promoter Group 0.0 0.0
Dhyanvi Patel Shareholding of Promoter and Promoter Group 0.0 0.0
Parthiv Patel Shareholding of Promoter and Promoter Group 0.0 0.0
Sanjay Rambhai Patel Shareholding of Promoter and Promoter Group 0.0 0.0
Chandrikaben Patel Shareholding of Promoter and Promoter Group 0.0 0.0
Shardaben Rambhai Patel Shareholding of Promoter and Promoter Group 0.0 0.0
Parul Patel Shareholding of Promoter and Promoter Group 0.0 0.0
Tresna Foundation Shareholding of Promoter and Promoter Group 0.0 0.0
Cinta Medtech Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
-Çÿhappynings Lifeskills LlpGÇÖ Earlier Known As -Çÿfootlights Theaters LlpGÇÖ Shareholding of Promoter and Promoter Group 0.0 0.0
Indubhushan Huf Shareholding of Promoter and Promoter Group 0.0 0.0
Eris Lifesciences Private Limited Group Gratuity Trust Shareholding of Promoter and Promoter Group 0.0 0.0
Eris Foundation Shareholding of Promoter and Promoter Group 0.0 0.0
Horizon Blue Ventures Llp Shareholding of Promoter and Promoter Group 0.0 0.0
Amit Bakshi (huf) Shareholding of Promoter and Promoter Group 0.0 0.0
Amit Somnat Mehrotra Shareholding of Promoter and Promoter Group 0.0 0.0
Shashi Somnat Shareholding of Promoter and Promoter Group 0.0 0.0
Somnat Mehrotra Shareholding of Promoter and Promoter Group 0.0 0.0
Parv Amit Bakshi Shareholding of Promoter and Promoter Group 0.0 0.0
Gauri Sachin Shah Shareholding of Promoter and Promoter Group 0.0 0.0
Nira Indubhushan Bakshi Shareholding of Promoter and Promoter Group 0.0 0.0
Indubhushan Bakshi Shareholding of Promoter and Promoter Group 0.0 0.0
Rangoli Amit Bakshi Shareholding of Promoter and Promoter Group 0.0 0.0
Inderjeet Singh Negi Huf Shareholding of Promoter and Promoter Group 0.0 0.0
Upender Singh Rawat Shareholding of Promoter and Promoter Group 0.0 0.0
Sandeepa Rawat Shareholding of Promoter and Promoter Group 0.0 0.0
Rameshwari Devi Rawat Shareholding of Promoter and Promoter Group 0.0 0.0
Shiv Chanran Singh Rawat Shareholding of Promoter and Promoter Group 0.0 0.0
Aditi Negi Shareholding of Promoter and Promoter Group 0.0 0.0
Manvendra Singh Negi Shareholding of Promoter and Promoter Group 0.0 0.0
Asha Rawat Shareholding of Promoter and Promoter Group 0.0 0.0
Rekha Rawat Shareholding of Promoter and Promoter Group 0.0 0.0
Rajeshwari Negi Shareholding of Promoter and Promoter Group 0.0 0.0
Sateshwari Devi Shareholding of Promoter and Promoter Group 0.0 0.0
Suman Negi Shareholding of Promoter and Promoter Group 0.0 0.0
Sarthak Negi Shareholding of Promoter and Promoter Group 100.0 0.0

ERIS LIFESCIENCES LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2022-08-11 7.35 Interim 2022-08-16 Equity shares 2021-08-05 6.01 Interim 2021-08-06 Equity shares 2020-08-13 5.5 Interim 2020-08-14 Equity shares 2020-03-19 2.87 Interim 2020-03-20 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About ERIS LIFESCIENCES LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by ERIS LIFESCIENCES LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of ERIS Lifesciences Ltd?

Answer Field

The share price of ERIS Lifesciences Ltd for NSE is ₹ 897.25 and for BSE is ₹ 892.5.

What is the Market Cap of ERIS Lifesciences Ltd?

Answer Field

The market cap of ERIS Lifesciences Ltd for NSE is ₹ 12,201.90 Cr. and for BSE is ₹ 12,137.31 Cr. as of now.

What is the 52 Week High and Low of ERIS Lifesciences Ltd?

Answer Field

The 52 Week High and Low of ERIS Lifesciences Ltd for NSE is ₹ 971.90 and ₹ 605.00 and for BSE is ₹ 971.00 and ₹ 605.20.

How to Buy ERIS Lifesciences Ltd share?

Answer Field

You can trade in ERIS Lifesciences Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for ERIS Lifesciences Ltd?

Answer Field

The 1 year returns on the stock has been 39.24%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader